Danielle Brill
Stock Analyst at Truist Financial
(4.48)
# 1,112
Out of 5,060 analysts
414
Total ratings
48.4%
Success rate
10.2%
Average return
Main Sectors:
Stocks Rated by Danielle Brill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRON Disc Medicine | Maintained: Buy | $115 | $56.84 | +102.32% | 23 | Oct 19, 2026 | |
| WVE Wave Life Sciences | Reiterated: Buy | n/a | $3.13 | - | 4 | Oct 2, 2026 | |
| IMVT Immunovant | Reiterated: Hold | n/a | $26.73 | - | 16 | Sep 24, 2026 | |
| RAPP Rapport Therapeutics | Reiterated: Buy | n/a | $27.57 | - | 5 | Sep 23, 2026 | |
| VRTX Vertex Pharmaceuticals | Reiterated: Buy | n/a | $499.74 | - | 11 | Sep 23, 2026 | |
| MAZE Maze Therapeutics | Reiterated: Buy | $64 | $27.53 | +132.47% | 6 | Sep 22, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | n/a | $231.83 | - | 19 | Sep 18, 2026 | |
| CLYM Climb Bio | Reiterated: Buy | n/a | $9.82 | - | 8 | Sep 4, 2026 | |
| SLDB Solid Biosciences | Initiated Coverage: Buy | $20 | $5.53 | +261.66% | 1 | Aug 21, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $1,030 → $1,095 | $819.14 | +33.68% | 34 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $102 → $107 | $66.39 | +61.17% | 15 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 → $25 | $2.76 | +805.80% | 7 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $195 | $96.27 | +102.56% | 10 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $20.65 | +190.56% | 12 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $616 | $241.76 | +154.80% | 3 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $128 | $72.09 | +77.56% | 9 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $29 → $34 | $37.98 | -10.48% | 20 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $207 | $120.30 | +72.07% | 13 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 → $213 | $135.77 | +56.88% | 24 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $235 | $232.65 | +1.01% | 19 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $9.04 | $21.78 | n/a | 23 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $6.93 | n/a | 3 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $19.12 | n/a | 19 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $51 | $31.32 | n/a | 3 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $79 | $54.68 | n/a | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $17.61 | n/a | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $59.24 | n/a | 21 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $150 | $17.10 | n/a | 36 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $52 → $50 | $33.49 | n/a | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.85 | n/a | 19 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $10 | $3.50 | n/a | 5 | May 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $13.37 | n/a | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $45 | $10.66 | n/a | 2 | May 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $41.22 | n/a | 10 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $157.14 | n/a | 1 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $11.84 | n/a | 5 | Nov 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $156.19 | n/a | 1 | Jul 26, 2016 |
Disc Medicine
Oct 19, 2026
Maintained: Buy
Price Target: $115
Current: $56.84
Upside: +102.32%
Wave Life Sciences
Oct 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.13
Upside: -
Immunovant
Sep 24, 2026
Reiterated: Hold
Price Target: n/a
Current: $26.73
Upside: -
Rapport Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $27.57
Upside: -
Vertex Pharmaceuticals
Sep 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $499.74
Upside: -
Maze Therapeutics
Sep 22, 2026
Reiterated: Buy
Price Target: $64
Current: $27.53
Upside: +132.47%
Alnylam Pharmaceuticals
Sep 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $231.83
Upside: -
Climb Bio
Sep 4, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.82
Upside: -
Solid Biosciences
Aug 21, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $5.53
Upside: +261.66%
argenx SE
Aug 18, 2026
Reiterated: Buy
Price Target: $1,030 → $1,095
Current: $819.14
Upside: +33.68%
Aug 12, 2026
Reiterated: Buy
Price Target: $102 → $107
Current: $66.39
Upside: +61.17%
Aug 12, 2026
Reiterated: Buy
Price Target: $43 → $25
Current: $2.76
Upside: +805.80%
Aug 10, 2026
Reiterated: Buy
Price Target: $195
Current: $96.27
Upside: +102.56%
Aug 10, 2026
Reiterated: Buy
Price Target: $60
Current: $20.65
Upside: +190.56%
Aug 7, 2026
Reiterated: Buy
Price Target: $616
Current: $241.76
Upside: +154.80%
Aug 6, 2026
Reiterated: Buy
Price Target: $128
Current: $72.09
Upside: +77.56%
Aug 5, 2026
Reiterated: Hold
Price Target: $29 → $34
Current: $37.98
Upside: -10.48%
Aug 5, 2026
Reiterated: Buy
Price Target: $207
Current: $120.30
Upside: +72.07%
Aug 3, 2026
Reiterated: Buy
Price Target: $200 → $213
Current: $135.77
Upside: +56.88%
Jul 31, 2026
Reiterated: Buy
Price Target: $235
Current: $232.65
Upside: +1.01%
Dec 10, 2024
Reiterated: Buy
Price Target: $20 → $9.04
Current: $21.78
Upside: n/a
Nov 18, 2024
Reiterated: Buy
Price Target: $18
Current: $6.93
Upside: n/a
Oct 10, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $19.12
Upside: n/a
Oct 10, 2024
Initiated Coverage: Buy
Price Target: $51
Current: $31.32
Upside: n/a
Oct 10, 2024
Initiated Coverage: Buy
Price Target: $79
Current: $54.68
Upside: n/a
Oct 10, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $17.61
Upside: n/a
Oct 10, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $59.24
Upside: n/a
Oct 10, 2024
Initiated Coverage: Buy
Price Target: $150
Current: $17.10
Upside: n/a
Oct 10, 2024
Initiated Coverage: Buy
Price Target: $52 → $50
Current: $33.49
Upside: n/a
Jun 26, 2023
Downgraded: Hold
Price Target: n/a
Current: $4.85
Upside: n/a
May 16, 2022
Reiterated: Buy
Price Target: $24 → $10
Current: $3.50
Upside: n/a
Jun 30, 2021
Initiated Coverage: Hold
Price Target: n/a
Current: $13.37
Upside: n/a
May 27, 2020
Reiterated: Buy
Price Target: $35 → $45
Current: $10.66
Upside: n/a
Feb 13, 2020
Reiterated: Hold
Price Target: n/a
Current: $41.22
Upside: n/a
Dec 16, 2019
Reiterated: Buy
Price Target: $125
Current: $157.14
Upside: n/a
Nov 7, 2019
Reiterated: Hold
Price Target: $6 → $5
Current: $11.84
Upside: n/a
Jul 26, 2016
Downgraded: Hold
Price Target: n/a
Current: $156.19
Upside: n/a